Skip to main content
. 2022 Dec 13;13:1060768. doi: 10.3389/fendo.2022.1060768

Table 2.

Subgroup analysis of OS (OR, 95% CI) .

Subgroup 1-year 3-year 5-year
Country
 China 1.23 (0.83–1.84) 1.54 (0.97–2.45) 1.86 (1.01–3.42)
 South Korea 1.15 (0.92–1.44) 1.49 (1.19–1.86) 1.84 (1.40–2.41)
Curative therapy
 RFA 1.33 (0.59–2.99) 1.52 (0.52–4.47)
 SBRT 1.13 (0.53–2.43) 2.05 (0.85–4.93)
 Hepatic resection 1.17 (0.94–1.44) 1.47 (1.19–1.82) 1.84 (1.43–2.36)

RFA, radiofrequency ablation; SBRT, stereotactic body radiotherapy.